- Home
- ASC vs TOI Comparison
ASC vs TOI Comparison
Compare ASC & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASC
- TOI
- Stock Information
- Founded
- ASC 2010
- TOI 2007
- Country
- ASC Bermuda
- TOI United States
- Employees
- ASC N/A
- TOI N/A
- Industry
- ASC Marine Transportation
- TOI Medical/Nursing Services
- Sector
- ASC Consumer Discretionary
- TOI Health Care
- Exchange
- ASC Nasdaq
- TOI Nasdaq
- Market Cap
- ASC 399.7M
- TOI 393.4M
- IPO Year
- ASC 2013
- TOI N/A
- Fundamental
- Price
- ASC $10.65
- TOI $3.76
- Analyst Decision
- ASC Buy
- TOI Strong Buy
- Analyst Count
- ASC 3
- TOI 1
- Target Price
- ASC $12.67
- TOI $6.00
- AVG Volume (30 Days)
- ASC 603.2K
- TOI 1.9M
- Earning Date
- ASC 07-30-2025
- TOI 08-13-2025
- Dividend Yield
- ASC 8.92%
- TOI N/A
- EPS Growth
- ASC N/A
- TOI N/A
- EPS
- ASC 1.04
- TOI N/A
- Revenue
- ASC $324,200,000.00
- TOI $424,376,000.00
- Revenue This Year
- ASC N/A
- TOI $19.40
- Revenue Next Year
- ASC N/A
- TOI N/A
- P/E Ratio
- ASC $10.11
- TOI N/A
- Revenue Growth
- ASC N/A
- TOI 17.53
- 52 Week Low
- ASC $8.32
- TOI $0.13
- 52 Week High
- ASC $20.17
- TOI $4.50
- Technical
- Relative Strength Index (RSI)
- ASC 53.93
- TOI 53.14
- Support Level
- ASC $10.17
- TOI $3.50
- Resistance Level
- ASC $10.65
- TOI $4.50
- Average True Range (ATR)
- ASC 0.43
- TOI 0.32
- MACD
- ASC -0.04
- TOI -0.06
- Stochastic Oscillator
- ASC 39.67
- TOI 35.65
About ASC Ardmore Shipping Corporation
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.